concluded that folate in serum was bound nonspecifically and weakly to serum proteins,predominantly by albumin.
Mantzos et al. (23) showed avid binding of folates by the serum of pigsand some sheep. Waxman (24, 25) found on Sephadex gel filtration that [3H]PGA was bound in serum of folatedeficientor uremic patientsto proteins of either50000 or 200 000 mol wt.
Thus, it appears that folate may be bound to proteins in principallytwo ways: (a)firmlyto specific globulins, with an affinityhigh enough to withstand charcoal treatment, electrophoresis, and chromatography; and (b) loosely and nonspecifically to albumin, as demonstrable by ultrafiltration and equilibrium dialysis.
In the following, we report on the separation of FBP in human serum by DEAE-cellulose chromatography before and aftercomplexing with [3H]PGA, and after dialysisor charcoal adsorption.
Materials
Tris buffer. 0.2 mol/liter, pH 8.0.
[ 3', acid, sodium salt ([3H] -PGA, 20 Ci/mmol; Amersham/Searle Corp., Arlington Heights, Ill. 60005).
Since the purity of thiscompound, when checked in competitive binding experiments, was considerably less than the 98% stated by the manufacturer, the radiochemical was purifiedby the column-chromatographic procedure of Nixon and Bertino (26) , except that mercaptoethanol was omitted from the elutingbuffers. The results were essentially the same as described previously (4 (27) and Rothenberg et al. (28) . Only two peaks of protein are seen, presumably because of precipitation of eugiobulins during dialysis. 
Fraction number

Sample Preparation for Chromatography
The working solutionof [3H]PGA was diluted sixfoldwith Tris buffer,and 6 ml was applied to the column.
(b) Serum pool as described above. The protein as described under paragraph c was adsorbed with PVP-charcoal.
To circumvent the introduction of undesirably large amounts of PVP into the chromatography procedure, 9 ml of the suspension of PVP-charcoal were centrifugedto obtain a sediment button of 450 mg. The supernatant buffer (which contained most of the PVP) was drained off, 9 ml of the sample as described under c was added, and the charcoal was resuspended for 5 mm to adsorb the free radioactivity. After centrifugation, 5 ml of the supernate was applied to the column forchromatography. Heat Dissociability
Aliquots of the fractions containing the bound radioactivity were heated for 10 mm in a boiling water bath and centrifuged to remove precipitated proteins. The supernate, after cooling to room temperature, was then treated with PVP-coated charcoal to adsorb radioactivity liberated by heating from its complex with protein.
Binding of Radioactivity in the
Eluates by Milk Binder Portions of 0.5 ml of the eluted fractions representing the free radioactivity were mixed with 100 il of a working dilution of the cows' milk folate binder and allowed to complex at room temperature for 30 mm. The mixture was then adsorbed with 0. 
Results
The results of the column chromatographic studies are summarized in Figure 1 .
The elution pattern shows one peak of radioactivity, in fractions 288 through 315. The radioactivity in this peak was adsorbable by Uncoated and PVP charcoal, was bindable by cows' milk folate binder, and thus reacted as a chemically intact, free folate. in two peaks, the first with the starting buffer, sodium phosphate (1 mmol/liter, pH 6.0), the second during a linear concentration gradient at 80-100 mmol/liter of sodium phosphate, pH 7.4. On Sephadex filtration, the FBP of the material represented by the first peak had a molecular weight of about 34 500 and the FBP in the second peak a molecular weight of 41 500. Waxman and Schreiber (31) extracted by affinity chromatography the low-molecular-weight component of human milk FBP, and chromatographed this material on DEAE-cellulose.
This FBP eluted in a single peak with a 1 mmol/liter phosphate buffer of pH 6.3. With this buffer system, the first protein peak as shown in panel c of Figure 1 now resolved into two well-separated peaks, the first containing about 70%, the second 30% of the protein. The [3H]PGA-FBP complex overlapped exactly with the second protein peak; however, no splitting or broadening of the radioactive peak was seen. These preliminary results show that, similar to FBPs from other sources (30, 31) , serum FBP can be eluted with buffers of very low ionic strength, and this should prove to be of great advantage in further purification and isolation efforts. The refinement of these DEAE-cellulose separation techniques are under study in our laboratory with the aim of isolating sufficient quantities of serum FBP(s) for more defmitive characterization that will form the basis of a future report.
On Sephadex gel filtration (24,25), [3H] PGA, when complexed with the serum of uremics or some folatedeficient patients, eluted as a sharp peak associated with proteins of 50000 mol wt. This material appears to correspond well with the FBP found in our studies, especially in view of the fact that our serum pool also contained sera from two patients with uremia. Waxman, however, also showed that an FBP of estimated molecular weight 200 000 was present in the serum of a folic acid-deficient patient. We examined the DEAE-cellulose eluted fractions of our material containing the FBP by Sephadex filtration and found only a single peak of bound E3HIPGA, associated with the proteins of approximately 50000 mol wt. Our findings are somewhat at variance with the conclusions presented by Markkanen et al. (9, 10) Folate binding proteins are widely distributed in mammalian tissues; they have been found to be present in such varied locations as leukocytes from patients with chronic myelogenous leukemia (2, 30) , the brush border membranes of small intestinal epithelial cells of rats (32) , hog kidney (33) , rat liver cells (34) , and human (31) and cows' milk (27) . FBP appears to be consistently present in high concentrations in these locations. In contrast to this, the concentrations of FBP in human serum vary considerably (4) . Some normal persons seem entirely to lack FBP in their serum. It is somewhat difficult to visualize a distinct physiological function for FBP in serum in view of such great quantitative variability. Waxman (25) has suggested that FBP in serum may be the result of increased cellular synthesis and its release in conditions such as leukemia or folate deficiency. We should like to add the possibility that FBP may be released into the blood stream at increased rates in conditions that are characterized by increased turnover, destruction, or wasting of FBP-containing tissues. These general conditions appear to have been present in the patients whose sera we selected for our study on the basis of their increased content of FBP: malignancies, uremia, pneumonia, injuries, intestinal bleeding, surgery, liver disease, and infarction.
Thus, FBP in serum may not have an essential physiological role, but may be incidental to tissue turnover. Finally, we should like to make the following quantitative considerations.
The binding capacity of a given amount of FBP is fixed and saturable, with an affinity that is highly specific (4) . These characteristics, of course, imply a stoichiometric relationship between folate and FBP. If one assumes that one molecule of serum FBP binds one molecule of folate (and the binding data in (31) seem to support this concept for human milk FBP), then the molar concentration of FBP in serum should approximate that of serum folates, which ranges from 5 to 50 nmol/liter. Consequently, with a 50000 mol wt, the concentration of FBP in serum should then range from 0.25 to 2.5 mg/liter, and with a 200 000 mol wt from 1 to 10 mg/liter. These quantitative relationships would seem to exclude major serum proteins that are known to be homogeneous entities from considerations as specific folate binders, that is to say, proteins such as transferrin or albumin (but not necessarily the heterogeneous a2-macroglobulin), the molar concentrations of which in serum typically exceed those of folates by two to three orders of magnitude. For purified transferrin, experimental evidence has been presented (16) indicating that it lacks folate binding properties.
As has also been pointed out by others (5, 25) the investigation of the FBPs is only at its beginning.
It is to be hoped that the interest recently awakened by several groups of workers will eventually result in the elucidation of the many questions that the discovery of the FBPs has raised.
